USB
42
-4
CHK
14
-7
O
37
-5
ECL
64
-6
TGT
43
-2
IP
65
-2
JCI
32
-3
OKE
64
2
KMI
61
-2
PGR
65
-4
BF.B
48
-5
GD
59
-5
GM
63
-3
AZO
59
-4
EMN
66
-6
WU
26
-6
AMGN
52
-5
HP
40
3
HPE
57
4
WY
37
-5
USB
42
-4
CHK
14
-7
O
37
-5
ECL
64
-6
TGT
43
-2
IP
65
-2
JCI
32
-3
OKE
64
2
KMI
61
-2
PGR
65
-4
BF.B
48
-5
GD
59
-5
GM
63
-3
AZO
59
-4
EMN
66
-6
WU
26
-6
AMGN
52
-5
HP
40
3
HPE
57
4
WY
37
-5
Financhill
Back

iShares S&P Mid-Cap 400 Value ETF Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
33

IJJ
iShares S&P Mid-Cap 400 Value ETF

Last Price:
112.58
Seasonality Move:
0.38%
Sell
44

RARE
Ultragenyx Pharmaceutical

Last Price:
40.51
Seasonality Move:
-0.9%
Sell
33
iShares S&P Mid-Cap 400 Value ETF (IJJ) is a Sell

Is iShares S&P Mid-Cap 400 Value ETF a Buy, Sell or Hold?

  • The current iShares S&P Mid-Cap 400 Value ETF [IJJ] share price is $112.50. The Score for IJJ is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • IJJ is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $40.50. The Score for RARE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IJJ Stock Price Chart

What is iShares S&P Mid-Cap 400 Value ETF's stock price today?

  • The iShares S&P Mid-Cap 400 Value ETF share price today is $112.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IJJ is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $40.50
    The current trend is relatively stagnant and RARE is experiencing slight buying pressure.

IJJ Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.56 Sell
Relative Strength Index (14 RSI): 43.33 Sell
Chaikin Money Flow: 44087 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (112.72 - 115.44) Sell
Bollinger Bands (100): (111.5 - 115.94) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 49.22 Sell
Chaikin Money Flow: 494801 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (38.79 - 41.97) Buy
Bollinger Bands (100): (40.81 - 48.79) Sell

IJJ Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 112.82 Sell
20-day SMA: 113.71 Sell
50-day SMA: 113.95 Sell
200-day SMA: 109.23 Buy
8-day EMA: 113.02 Sell
20-day EMA: 113.6 Sell
50-day EMA: 113.95 Sell
200-day EMA: 110.86 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 39.2 Buy
20-day SMA: 40.42 Buy
50-day SMA: 41.53 Sell
200-day SMA: 42.45 Sell
8-day EMA: 39.89 Buy
20-day EMA: 40.39 Buy
50-day EMA: 41.79 Sell
200-day EMA: 43.35 Sell

iShares S&P Mid-Cap 400 Value ETF Earnings Growth & IJJ Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.51 per share, an increase next quarter of $0.03 per share, an increase this year of $0.94 per share, and an increase next year of $1.06 per share.

iShares S&P Mid-Cap 400 Value ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):